Browse Category

Stocks News 5 November 2025 - 11 November 2025

UAMY Stock Skyrockets on $245M Pentagon Deal – Bubble or Buy?

UAMY Stock Today (Nov. 11, 2025): United States Antimony Jumps on $106.7M Five‑Year Supply Deal as China Eases Antimony Export Ban; Q3 Results Due Tomorrow

Updated November 11, 2025 Key takeaways UAMY stock news today (Nov. 11, 2025) US Antimony signs $106.7M, five‑year supply deal. Before the bell, USAC announced a definitive five‑year agreement to supply antimony trioxide—used primarily as a flame‑retardant synergist for industrial fabrics—to a U.S.‑based manufacturer. The company notes the customer completed materials testing earlier in 2025, and the contract includes a five‑year renewal option beyond the initial term.…
Brookfield Renewable (BEP) Slides After $650M Equity Raise: Proceeds Target Isagen Stake & Baseload Growth (11/11/2025)

Brookfield Renewable (BEP) Slides After $650M Equity Raise: Proceeds Target Isagen Stake & Baseload Growth (11/11/2025)

Brookfield Renewable Partners L.P. (NYSE: BEP; TSX: BEP.UN) traded lower today after unveiling a fresh equity financing package tied to its push into “firm” clean power—including hydro and nuclear—and the recently completed increase in its stake in Colombia’s Isagen. Here’s what changed today, why it matters, and what’s next for investors. Key takeaways What happened today BEP units fell in…
Rolls-Royce Soars to Record High: What’s Fueling the Unstoppable Rally?

Rolls‑Royce (RRL.XC / RR.L) Stock Today: Buyback Update, Insider Purchases & What to Watch Ahead of Thursday’s Trading Statement — 11 November 2025

London — 11 November 2025. Rolls‑Royce Holdings plc shares ended the session around 1,151.5p in London (‑0.82% on the day), trading between 1,144.5p and 1,168.5p and sitting within a 52‑week range of 517.2p–1,196.0p. Figures are based on LSEG/Reuters data for the LSE‑listed RR.L line. Reuters Key takeaways (11 Nov 2025) What happened today 1) Transaction in own shares (11 Nov…
Berkshire Hathaway’s Next Act: Trillion-Dollar BRK-B, Buffett’s Farewell & 2025 Forecasts

BRK.A Stock Before the Bell (Nov 10, 2025): Record $381.7B Cash, OxyChem Deal Nears, PacifiCorp Risks, and Key Catalysts This Week

Date: Monday, November 10, 2025 Key takeaways Why the cash mountain matters before the openBerkshire finished Q3 with roughly $381.7 billion in cash and short‑term Treasuries—a U.S. corporate record. The scale of that reserve signals management’s caution on dealmaking and public‑equity valuations heading into year‑end, and it gives Berkshire unusual optionality if markets wobble. Note that Berkshire’s 10‑Q also highlights…
Dow Dips as Fed Fears Slam Tech Stocks – Hot Economic Data Rattles Wall Street (Sept 25, 2025)

Comcast (CMCSA) Stock Today — Nov. 7, 2025: Sky–ITV Talks and a Potential WBD Bid Put M&A in Focus as Shares Hover Near $27

Published: November 7, 2025 Key takeaways Comcast stock price snapshot (Nov. 7, 2025) Comcast Corporation (NASDAQ: CMCSA) traded modestly lower today, holding near the $27 handle. As of 19:33 UTC (2:33 p.m. ET), the stock printed $27.28 after opening at $27.56, with volume around 20.9 million shares. Intraday, CMCSA ranged $27.02–$27.77, reflecting an active tape as investors reacted to fresh…
Petrobras (PBR) jumps on Q3 results, R$12.16bn dividend and faster capex — Today, 7 November 2025

Petrobras (PBR) jumps on Q3 results, R$12.16bn dividend and faster capex — Today, 7 November 2025

Petróleo Brasileiro S.A. (Petrobras) shares are higher today after the company’s third‑quarter print, a fresh dividend announcement and upbeat commentary on its 2025 investment pace. By 19:25 UTC, U.S.-listed PBR ADRs traded around $12.71 (≈+4.7% on the day) and PBR.A near $11.92 (≈+3.0%). Brazilian preferreds PETR4 were also firmer in São Paulo around midday, at R$31.90 (≈+2.7%). InfoMoney Key takeaways…
Wendy’s (WEN) pops after Q3 beat as ‘Project Fresh’ adds store-closure plan — Nov. 7, 2025

Wendy’s (WEN) pops after Q3 beat as ‘Project Fresh’ adds store-closure plan — Nov. 7, 2025

The Wendy’s Company (NASDAQ: WEN) beat Q3 estimates, declared a $0.14 dividend, outlined 2025 guidance, and said a mid‑single‑digit percentage of U.S. restaurants could close under its new “Project Fresh” turnaround. Here’s what investors need to know today. Wendy’s delivered an earnings beat this morning and doubled down on a major turnaround called Project Fresh. Results were mixed: international momentum…
Hecla Mining (HL) Soars on Record Q3 2025: $409.5M Revenue, $0.15 EPS, Dividend Declared — What to Know Today (Nov 6, 2025)

Hecla Mining (HL) Soars on Record Q3 2025: $409.5M Revenue, $0.15 EPS, Dividend Declared — What to Know Today (Nov 6, 2025)

Hecla Mining Company (NYSE: HL) is in focus today after reporting record third‑quarter results last night and hosting its earnings call this morning. The silver producer posted all‑time‑high quarterly revenue and net income, tightened 2025 production guidance, detailed permitting wins, and declared dividends on both common and preferred shares. Shares are trading sharply higher intraday amid the news. Q4Web Key…
Comstock Resources (CRK) Jumps as Q3 Results, $430M Divestiture and Rising RS Rating Put Haynesville Gas in Focus — Nov. 6, 2025

Comstock Resources (CRK) Jumps as Q3 Results, $430M Divestiture and Rising RS Rating Put Haynesville Gas in Focus — Nov. 6, 2025

FRISCO, Texas — Nov. 6, 2025. Shares of Comstock Resources, Inc. (NYSE: CRK) traded higher today after a week packed with catalysts: stronger third‑quarter results, progress on a $430 million asset sale, and a fresh technical tailwind as the stock’s Relative Strength (RS) rating ticked up. Midday, CRK changed hands around $21.14, up roughly 5.5%, within a 52‑week range of…
Moderna (MRNA) Beats Q3 on Sales of New COVID Shot, Trims 2025 Outlook; Stock Whipsaws — Nov. 6, 2025

Moderna (MRNA) Beats Q3 on Sales of New COVID Shot, Trims 2025 Outlook; Stock Whipsaws — Nov. 6, 2025

Moderna, Inc. (NASDAQ: MRNA) posted third‑quarter 2025 revenue of ~$1.02 billion and a GAAP loss of $0.51 per share, topping Wall Street estimates as sales of its updated COVID‑19 vaccine outperformed. The company narrowed its full‑year revenue range to $1.6–$2.0 billion, cut operating‑expense guidance, and raised its year‑end cash outlook. Shares popped in pre‑market trading before wobbling intraday. SEC What…
Cipher Mining Stock Skyrockets on Blockbuster AWS Deal – Latest Earnings, Expert Insights & Price Forecast

Cipher Mining Stock Skyrockets on Blockbuster AWS Deal – Latest Earnings, Expert Insights & Price Forecast

Stock Performance and Recent Trends (Past Week) Cipher Mining’s stock has been on a tear. In the final week of October into early November 2025, CIFR rocketed from the high teens to the mid-$20s per share Stockanalysis Stockanalysis. On Monday, Nov 3, shares opened slightly down but closed up over 22% in a single session 247Wallst – an eye-popping move…
Biohaven (BHVN) Stock Plunges on FDA Setback – Will Its Biotech Pipeline Fuel a Comeback?

Biohaven (BHVN) Stock Plunges on FDA Setback – Will Its Biotech Pipeline Fuel a Comeback?

FDA Setback: Complete Response Letter Halts Lead Drug Ambitions Biohaven’s recent troubles center on VYGLXIA (troriluzole) – its lead drug candidate for spinocerebellar ataxia (SCA), a degenerative brain disorder that currently has no approved treatment Reuters. On November 4, 2025, after market close, Biohaven announced that the FDA had issued a Complete Response Letter (CRL) rejecting the company’s New Drug…
1 71 72 73 74 75 89

Stock Market Today

  • New Price Target Sparks Fresh Analysis on Hiscox (LSE:HSX) Shares
    January 21, 2026, 10:53 PM EST. Hiscox (LSE:HSX) recently received a new analyst price target, reshaping investor perspectives on the insurer's valuation. This benchmark provides a reference point amid varied risks such as underwriting discipline and exposure to large claims events. The updated target encourages shareholders to reassess earnings quality, capital strength, and fair value assumptions. Investors are advised to consider this price target as part of a broader valuation range, not a precise forecast, due to differing opinions on Hiscox's future prospects. Simply Wall St's platform offers tools for tracking narrative changes, comparing analyst views, and adjusting investment strategies based on evolving market data and forecasts.
Go toTop